🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now in Cancer Discovery: Pharmacological reduction of #mitochondrial iron triggers non-canonical BAX/BAK dependent #celldeath by sylvain garciaz Raphaël Rodriguez Mark Dawson The Dawson Lab et al Institut Paoli-Calmettes (IPC) CRCM - Cancer Research Centre of Marseille Institut Curie Peter Mac Cancer Centre @UMCCR cancerdiscovery.aacrjournals.org/content/early/…

starve leukemia iron levels plunge with drugs unorthodox death #haiku #paperoftheday from sylvain garciaz, Mark Dawson The Dawson Lab, Raphaël Rodriguez, & colleagues in Cancer Discovery: cancerdiscovery.aacrjournals.org/content/early/…

cancerdiscovery.aacrjournals.org/content/early/…

Un fantastique travail collaboratif entre les équipes de recherche de Marseille, Paris et Melbourne publié dans Cancer Discovery aujourd’hui. Une nouvelle molécule dans la lutte contre les leucémies. L’IPC combat le cancer Institut Paoli-Calmettes (IPC) cancerdiscovery.aacrjournals.org/content/early/…

L'IPC toujours à l'avant-garde de la lutte contre le cancer. Félicitation aux équipes et à ce beau travail collaboratif. 👏👏

Very excited to share our latest study published today ⁦Cancer Discovery⁩ - a wonderful collaboration between ⁦The Dawson Lab⁩, Raphael Rodriguez ⁦Institut Curie. Congratulations to first author sylvain garciaz cancerdiscovery.aacrjournals.org/content/early/…

Iron-reducing drug – ironomycin - starves acute leukaemia cells then kills them, finds new research by Mark Dawson, sylvain garciaz at Peter Mac Cancer Centre, Institut Curie & Institut Paoli-Calmettes (IPC) published overnight in Cancer Discovery. Read more: petermac.org/news/iron-redu…

sylvain garciaz Institut Paoli-Calmettes (IPC) Vive la recherche

sylvain garciaz Institut Paoli-Calmettes (IPC) Great!!

Congratulations sylvain garciaz Mark Dawson CRCM - Cancer Research Centre of Marseille Institut Paoli-Calmettes (IPC) @univamu

cc sylvain garciaz Mark Dawson

Pharmacological reduction of #mitochondrial iron triggers a non-canonical BAX/BAK dependent #celldeath. bit.ly/32SITKz sylvain garciaz, Raphaël Rodriguez, Mark Dawson, The Dawson Lab and colleagues Institut Paoli-Calmettes (IPC), CRCM - Cancer Research Centre of Marseille, Institut Curie, Peter Mac Cancer Centre, @UMCCR

📌 Leucémies aiguës : la découverte d’une molécule ciblant le fer peut permettre de traiter les leucémies résistantes aux traitements conventionnels 🧪🧫 Lire l'alerte presse 👉lnkd.in/d4XWjrjG

Targeting mitochondrial iron kills aml cells and synergies with Venetoclax! Saturday 11, 2:30 PM, oral session 802. ash.confex.com/ash/2021/webpr…

ICYMI in Cancer Discovery: Actinomycin D targets NPM1c-primed #mitochondria to restore PML-driven #senescence in AML therapy by Hughes de Thé and colleagues Collège de France Inserm @Univ_Paris Hôpital Saint-Louis AP-HP #leusm #ASH21 cancerdiscovery.aacrjournals.org/content/11/12/…

ICYMI in Cancer Discovery: An in vivo #CRISPR screening platform for prioritizing therapeutic targets in acute myeloid #leukemia Stegmaier Lab Dana-Farber Broad Institute #leusm #ASH21 cancerdiscovery.aacrjournals.org/content/early/…

The EACR's latest Top 10 Cancer Research Publications is available now. Curated by the EACR Board, it's a summary of the most interesting and impactful recent papers in #cancerresearch. Read it in #TheCancerResearcher: magazine.eacr.org/the-eacrs-top-…